Related references
Note: Only part of the references are listed.Resting heart rate in cardiovascular disease
Kim Fox et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2007)
Neuropeptide Y acts directly in the periphery on fat tissue and mediates stress-induced obesity and metabolic syndrome
Lydia E. Kuo et al.
NATURE MEDICINE (2007)
Risk factors for sudden cardiac death in patients with chronic renal insufficiency and left ventricular dysfunction
Michel Chonchol et al.
AMERICAN JOURNAL OF NEPHROLOGY (2007)
Mechanisms of sympathetic activation in obesity-related hypertension
Murray Esler et al.
HYPERTENSION (2006)
Associations of metabolic syndrome with inflammation in CKD: Results from the Third National Health and Nutrition Examination Survey (NHANES III)
S Beddhu et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2005)
Interactions between leptin and the human sympathetic nervous system
N Eikelis et al.
HYPERTENSION (2003)
Sympathetic neural activation in visceral obesity
GE Alvarez et al.
CIRCULATION (2002)
Plasma norepinephrine predicts survival and incident cardiovascular events in patients with end-stage renal disease
C Zoccali et al.
CIRCULATION (2002)
Reduction of inflammatory cytokine concentrations and improvement of endothelial functions in obese women after weight loss over one year
P Ziccardi et al.
CIRCULATION (2002)
Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)
JI Cleeman et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
Share Paper
